Pharma Mirror
OCTOBER 15, 2021
This filler-binder enablespharmaceutical and nutraceutical manufacturers to target consumers that have difficultyswallowing standard tablets. As a non-hygroscopic, water-soluble and directly compressibleexcipient, galenIQ™ 721 also provides high content uniformity and production efficiency foreffervescent applications.
Roots Analysis
JANUARY 3, 2024
Medical aesthetics is a growing area of modern medicine that focuses on improving the cosmetic appearance of an individual through various medical treatments. Afterwards, in 2003, the FDA approved Hyaluronic Acid Fillers (HA dermal fillers), bringing the much-anticipated innovation to all types of face and non-face augmentation products.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MARCH 12, 2021
Several cases of immune thrombocytopenia – a disorder characterised by low levels of blood platelets that can lead to bruising and bleeding – were reported in the European Medicines Agency’s safety surveillance database.
Roots Analysis
JANUARY 29, 2024
Medical Aesthetics is an area of modern medicine that specializes in improving the outer appearance of an individual without surgery. It is interesting to note that medical aesthetics companies are continuously enhancing their product portfolio to provide solutions based on the needs of the end user.
The Pharma Data
OCTOBER 22, 2021
Novartis blazoned moment that it has inked an original agreement to work its manufacturing capacity and capabilities to address the COVID-19 epidemic by expanding its support of the filler and finish of the Pfizer-BioNTech COVID-19 vaccine. This new agreement follows a first contract inked before this time.
The Pharma Data
MAY 7, 2021
During an early May meeting, the European Medicines Agency’s safety committee concluded two reviews of safety signals related to COVID-19 vaccines, while it continued following other vaccine-related “topics of interest.” Separately, EMA’s human medicines committee has begun a rolling review of another monoclonal antibody to treat COVID-19.
Pharmacy Checkers
NOVEMBER 12, 2020
Kesselheim and Bollyky write: “FDA approvals are specific to the information in the NDA or ANDA, including: the manufacturer, product, and its use; manufacturing location, formulation, source, and specifications of active ingredients; processing methods; manufacturing controls; labeling; and appearance.”. It’s a great plan!
Expert insights. Personalized for you.
100 
Let's personalize your content